Valproic Acid Enhanced Temozolomide-Induced Anticancer Activity in Human Glioma Through the p53-PUMA Apoptosis Pathway.

Saved in:
Bibliographic Details
Title: Valproic Acid Enhanced Temozolomide-Induced Anticancer Activity in Human Glioma Through the p53-PUMA Apoptosis Pathway.
Authors: Tsai HC; Department of Neurosurgery, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.; School of Traditional Chinese Medicine, Chang Gung University, Taoyuan, Taiwan., Wei KC; Department of Neurosurgery, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.; Department of Neurosurgery, New Taipei Municipal TuCheng Hospital, Chang Gung Memorial Hospital, New Taipei City, Taiwan.; Neuroscience Research Center, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.; School of Medicine, Chang Gung University, Taoyuan, Taiwan., Chen PY; School of Medicine, Chang Gung University, Taoyuan, Taiwan.; Department of Neurosurgery, Keelung Chang Gung Memorial Hospital, Keelung, Taiwan., Huang CY; Department of Neurosurgery, New Taipei Municipal TuCheng Hospital, Chang Gung Memorial Hospital, New Taipei City, Taiwan.; Neuroscience Research Center, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan., Chen KT; Department of Neurosurgery, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.; Neuroscience Research Center, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan., Lin YJ; Department of Neurosurgery, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.; School of Medicine, Chang Gung University, Taoyuan, Taiwan., Cheng HW; Department of Neurosurgery, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.; Institute of Pharmacology, College of Medicine, National Yang-Ming University, Taipei, Taiwan., Chen YR; Department of Neurosurgery, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan., Wang HT; Institute of Pharmacology, College of Medicine, National Yang-Ming University, Taipei, Taiwan.; Institute of Pharmacology, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.; Institute of Food Safety and Health Risk Assessment, National Yang Ming Chiao Tung University, Taipei, Taiwan.; Doctor Degree Program in Toxicology, Kaohsiung Medical University, Kaohsiung, Taiwan.
Source: Frontiers in oncology [Front Oncol] 2021 Oct 01; Vol. 11, pp. 722754. Date of Electronic Publication: 2021 Oct 01 (Print Publication: 2021).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34660288
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Valproic Acid Enhanced Temozolomide-Induced Anticancer Activity in Human Glioma Through the p53-PUMA Apoptosis Pathway.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Tsai+HC%22">Tsai HC</searchLink>; Department of Neurosurgery, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.; School of Traditional Chinese Medicine, Chang Gung University, Taoyuan, Taiwan.<br /><searchLink fieldCode="AU" term="%22Wei+KC%22">Wei KC</searchLink>; Department of Neurosurgery, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.; Department of Neurosurgery, New Taipei Municipal TuCheng Hospital, Chang Gung Memorial Hospital, New Taipei City, Taiwan.; Neuroscience Research Center, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.; School of Medicine, Chang Gung University, Taoyuan, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chen+PY%22">Chen PY</searchLink>; School of Medicine, Chang Gung University, Taoyuan, Taiwan.; Department of Neurosurgery, Keelung Chang Gung Memorial Hospital, Keelung, Taiwan.<br /><searchLink fieldCode="AU" term="%22Huang+CY%22">Huang CY</searchLink>; Department of Neurosurgery, New Taipei Municipal TuCheng Hospital, Chang Gung Memorial Hospital, New Taipei City, Taiwan.; Neuroscience Research Center, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chen+KT%22">Chen KT</searchLink>; Department of Neurosurgery, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.; Neuroscience Research Center, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.<br /><searchLink fieldCode="AU" term="%22Lin+YJ%22">Lin YJ</searchLink>; Department of Neurosurgery, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.; School of Medicine, Chang Gung University, Taoyuan, Taiwan.<br /><searchLink fieldCode="AU" term="%22Cheng+HW%22">Cheng HW</searchLink>; Department of Neurosurgery, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.; Institute of Pharmacology, College of Medicine, National Yang-Ming University, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chen+YR%22">Chen YR</searchLink>; Department of Neurosurgery, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.<br /><searchLink fieldCode="AU" term="%22Wang+HT%22">Wang HT</searchLink>; Institute of Pharmacology, College of Medicine, National Yang-Ming University, Taipei, Taiwan.; Institute of Pharmacology, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.; Institute of Food Safety and Health Risk Assessment, National Yang Ming Chiao Tung University, Taipei, Taiwan.; Doctor Degree Program in Toxicology, Kaohsiung Medical University, Kaohsiung, Taiwan.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2021 Oct 01; Vol. 11, pp. 722754. <i>Date of Electronic Publication: </i>2021 Oct 01 (<i>Print Publication: </i>2021).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34660288
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fonc.2021.722754
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 722754
    Titles:
      – TitleFull: Valproic Acid Enhanced Temozolomide-Induced Anticancer Activity in Human Glioma Through the p53-PUMA Apoptosis Pathway.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Tsai HC
      – PersonEntity:
          Name:
            NameFull: Wei KC
      – PersonEntity:
          Name:
            NameFull: Chen PY
      – PersonEntity:
          Name:
            NameFull: Huang CY
      – PersonEntity:
          Name:
            NameFull: Chen KT
      – PersonEntity:
          Name:
            NameFull: Lin YJ
      – PersonEntity:
          Name:
            NameFull: Cheng HW
      – PersonEntity:
          Name:
            NameFull: Chen YR
      – PersonEntity:
          Name:
            NameFull: Wang HT
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2021 Oct 01
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-print
              Value: 2234-943X
          Numbering:
            – Type: volume
              Value: 11
          Titles:
            – TitleFull: Frontiers in oncology
              Type: main
ResultId 1